News and musings from the Sprout team

In PM360 Magazine this month! – July 2020

In PM360 Magazine this month! – July 2020

Our co-founder Christina Jackson is one of a panel of industry experts discussing the barriers pharmaceutical companies can benefit from addressing. Her takeaway advice? Pharma needs to take more risks in being transparent with patients. ‘From my experience, pharma is...

read more
Emotional needs of CLN2 families

Emotional needs of CLN2 families

Our co-founder Lina Eliasson co-authored a recently published paper highlighting the need for emotional and practical support for families caring for a child with Neuronal Ceroid Lipofuscinosis Type 2 Disease (CLN2), a rare degenerative neurometabolic condition that...

read more
The EMERGE guideline on medicine adherence

The EMERGE guideline on medicine adherence

Sprout founders Lina Eliasson and Christina Jackson, and Sarah Clifford who recently launched our US office, have all worked on a fascinating new paper on the International Society for Medication Adherence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE)....

read more
Our new Hunter syndrome caregiver support program

Our new Hunter syndrome caregiver support program

We were very proud to present a poster on our nurse-delivered caregiver support program for Hunter syndrome at the 2019 Connect For Care, an international meeting for rare disease nurses. Hunter syndrome is a very rare inherited metabolic disorder, which can cause a...

read more
A new screener for monitoring adherence

A new screener for monitoring adherence

Our co-founder, Christina Jackson, has co-authored a newly published paper with academics at King’s College London, reporting on testing a brief screener to prompt discussions about adherence in routine consultations. The team worked with 161 people with type 2...

read more